Calcitriol 3 micrograms/g versus calcipotriol 50 micrograms/g for plaque psoriasis: treatment, maintenance and cost

被引：0

作者：

Gottschalk, Ronald W. ^{[1
]}

Johnson, Lori A. ^{[1
]}

机构：

[1] Galderma Lab, Ft Worth, TX USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2007年 / 56卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：AB179 / AB179

页数：1

共 50 条

[21] Cost-Effectiveness Analysis of Topical Calcipotriol versus Short- Contact DithranolIn the Treatment of Mild to Moderate Plaque Psoriasis
Darren M. Ashcroft
Alain Li Wan Po
Hywel C. Williams
Christopher E. M. Griffiths
PharmacoEconomics, 2000, 18 : 469 - 476
[22] A cost-effectiveness analysis of calcipotriol plus betamethasone dipropionate aerosol foam versus gel for the topical treatment of plaque psoriasis
Foley, Peter
Garrett, Sinead
Ryttig, Lasse
CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (07) : 1277 - 1283
[23] Scalp psoriasis:: Topical calcipotriol 50 μg/g/ml solution vs. betamethasone valerate 1% lotion
Duweb, GA
Abuzariba, O
Rahim, M
Al-Taweel, M
Abdulla, SA
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2000, 20 (3-4) : 65 - 68
[24] Calcitriol 3 μg/g Ointment: An Effective and Safe Addition to the Armamentarium in Topical Psoriasis Therapy
Abramovits, William
JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : S17 - S22
[25] Comparative evaluation of efficacy and safety of calcipotriol versus calcitriol ointment, both in combination with narrow-band ultraviolet B phototherapy in the treatment of stable plaque psoriasis
Chakraborty, Disha
Aggarwal, Kamal
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2023, 39 (05) : 512 - 519
[26] An Open-label, Multicenter Study of the Efficacy and Safety of a Weekday/Weekend Treatment Regimen With Calcitriol Ointment 3 μg/g and Clobetasol Propionate Spray 0.05% in the Management of Plaque Psoriasis
Hudson, Charles P.
Kempers, Steven
Menter, Alan
Papp, Kim
Smith, Stacy
Sofen, Howard
Colon, Luz E.
Johnson, Lori A.
Gottschalk, Ronald
CUTIS, 2011, 88 (04): : 201 - 207
[27] An Open-Label, Multicenter Study of the Efficacy and Safety of an AM/PM Treatment Regimen With Clobetasol Propionate Spray 0.05% and Calcitriol Ointment 3 μg/g in the Management of Plaque Psoriasis
Menter, Alan
Sofen, Howard
Smith, Stacy
Papp, Kim
Kempers, Steven
Hudson, Charles P.
Colon, Luz E.
Johnson, Lori A.
Gottschalk, Ronald
CUTIS, 2011, 88 (01): : 46 - 51
[28] Vasoconstrictor potency of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam versus other topical corticosteroids used to treat psoriasis vulgaris
Queille-Roussel, C.
Nielsen, J.
Lacour, J. -P.
JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (06) : 529 - 533
[29] Clinical, patient and estimated cost benefits of proactive management versus reactive management with calcipotriol/betamethasone dipropionate foam for the treatment of plaque psoriasis in Finland
Harvima, Rauno J.
Gooderham, Melinda
Tyring, Stephen
Thoning, Henrik
Nyholm, Nanna
Stein Gold, Linda
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2234 - 2240
[30] Topical use of calcitriol 3 μg/g ointment in the treatment of mild-to-moderate psoriasis:: results from an open-label study
Carboni, I
de Felice, C
Bergamin, A
Chimenti, S
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 : 11 - 13

← 1 2 3 4 5 →